ACM Biolabs develops novel vaccines and antibodies using proprietary artificial cell membrane technology.
ACM Biolabs was founded in 2013 by Madhavan Nallani.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 156 based in Asia-Pacific (APAC).
ACM Biolabs may be growing as evidenced by the positive topline results from a Phase I trial of their SARS-CoV-2 booster vaccine ACM-001. This achievement suggests progress in their product pipeline and potential for future revenue streams. The success of this trial could also enhance the company's reputation in the biotechnology and healthcare industries, possibly leading to increased investment or partnership opportunities. Furthermore, the development of a vaccine is a significant milestone for a company in the biotechnology sector, indicating a capacity for innovation and advancement in their field.
“ACM Biolabs is a biotechnology company pioneering innovative medicines through a next-generation polymer-based nanoparticle delivery technology platform” acmbiolabs.com
Founded in 2013, ACM Biolabs works in alternative medicine, biotechnology and health care from Asia-Pacific (APAC) and has 11-50 employees. It has raised $6.8 million over 3 rounds and its website drew about 1,277 visits in the latest month measured.
11-50 employees · acehomoeopathy.in
11-50 employees · 23strands.com
11-50 employees · abferopharmaceuticals.com
11-50 employees · achieveintegrativehealth.com
11-50 employees · adarx.com
11-50 employees · artbio.com
11-50 employees · activmedresearch.com
11-50 employees · adslaboratories.com
11-50 employees · accidentcentersoftexas.com
11-50 employees · airna.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.